Altimmune, Inc. (ALT) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.00 | +25.4% |
| 2024 | $-1.34 | +19.3% |
| 2023 | $-1.66 | +8.3% |
| 2022 | $-1.81 | +23.0% |
| 2021 | $-2.35 | -23.0% |
| 2020 | $-1.91 | — |
| 2016 | $2.95 | +6000.0% |
| 2015 | $-0.05 | +70.6% |
| 2014 | $-0.17 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.00 | +25.4% |
| 2024 | $-1.34 | +19.3% |
| 2023 | $-1.66 | +8.3% |
| 2022 | $-1.81 | +23.0% |
| 2021 | $-2.35 | -23.0% |
| 2020 | $-1.91 | — |
| 2016 | $2.95 | +6000.0% |
| 2015 | $-0.05 | +70.6% |
| 2014 | $-0.17 | — |